Tag Archive for: oral

Oral GLP-1 receptor agonists are the next big thing in weight management. However, gastrointestinal side effects caused by the high doses required for oral administration remain a challenge to be addressed.Adobe stock photos - Jim
Obesity

Lilly’s weight loss pill orforglipron meets primary Phase III endpoint

Eli Lilly, the US market leader in the lucrative diabetes and obesity space, is now challenging its competitor Novo Nordisk in the area of oral GLP-1 receptor agonists. Lilly’s orforglipron has met the primary endpoint of its registration study and is set to be submitted for approval in the United States.

Read more
LysosomesRomi - adobe stock.com
Financing

Azafaros BV bags €132m Series B financing

Belgian lysosomal storage disease specialist Azafaros BV has added a new lead investor to its portfolio. In addition to €25m Series A leader Forbion, Jeito Captial co-led a €132m Series B round aimed at advancing two pivotal trials of Azafaros‘ lead compound nizabagloustat (AZ-3102).

Read more